Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a physiological mechanism, not a discrete molecular target. Osmotic dehydration of blood at a bleeding site involves application of a hyperosmolar substance that extracts water from blood and tissue locally, resulting in a rapid increase in the concentration of clotting factors and platelets at the wound site. This process enhances coagulation and clot formation independently of specific receptor or enzyme targeting. It is a concept used in the design of certain topical hemostatic products but is not recognized as a traditional drug target or receptor[2][4][9].
Osmotic extraction of water from blood at the application site, leading to increased local concentration of clotting factors and platelets, thereby promoting clot formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic dehydration of blood at application site leading to concentration of clotting factors and platelets.